Epoch 23: Private Biotech Capital Allocation Trends 👉Favored therapeutic areas by investors 👉Which modalities are attracting capital 👉Guess which stages of development investors prefer? https://lnkd.in/dEkBy2bY
Bo wtiedBiotech’s Post
More Relevant Posts
-
EPOCH 30: BIOTECH MARKET RESEARCH $RVMD 🚨ALERT: RMC-6236 clinical update in Pancreatic Ductal Adenocarcinoma (PDAC) 📅DATE: July 15, 2024 📈📉IMPLIED VOLATILITY: +/- 60% https://lnkd.in/dEkBy2bY
-
-
Epoch 28: Raising Money in Biotech? Plan for Longer than Expected 👉 Macro picture crystallizing 👉 Biotech financing vs other industries? 👉 Round sizes under pressure 👉 Time to finance timeline elongating https://lnkd.in/dEkBy2bY
-
-
EPOCH 28: BIOTECH MARKET RESEARCH $GRTS 🚨ALERT: mature PFS data from GRANITE Ph2 📅DATE: Q3, 2024 📈📉IMPLIED VOLATILITY: +/- 70% https://lnkd.in/dEkBy2bY
-
-
Epoch 27: Trump vs Biden & How to Sanely Discuss Guess which candidate supports the following? 👉🏼 Higher taxes 👉🏼 Gov intervention in drug pricing 👉🏼 More stringent FTC & FDA 👉🏼 Restricting international trade law 👉🏼 More gov spending for NIH research 👉🏼 More spending for pandemic preparedness We will also cover tips for discussing politics at work https://lnkd.in/dfKQzmBQ
-
-
Epoch 27: Sweat Equity - Your Weekly Biotech News Fix 👉 A New Alzheimer's approval 👉 BCMA CAR-T autoimmune data 👉 Chevron ruling impacts to biotech 👉 Indian > China CDMO? And more! https://lnkd.in/dEkBy2bY
-
-
Epoch 27: Survival of the Fittest - Biotech Industry Faces Shutdowns & Consolidation 👉 New job opening data crumbles 👉 Venture backed shutdowns accelerate 👉 Historic summer financing trends https://lnkd.in/dEkBy2bY
-
-
Epoch 27: CRISPR Corner: Monthly Gene Editing Updates Designed to be read as a quick scroll with links to underlying articles, we highlight the biggest news in CRISPR over the past month 👉 CRISPR for bladder cancer 👉 New "Bridge Recombinase" system 🌉 👉 Redosable CRISPR in humans 👉 7 CRISPR Companies to watch in 2024 And more! https://lnkd.in/dEkBy2bY
-
-
EPOCH 27: BIOTECH MARKET RESEARCH $PFE 🚨ALERT: Phase I study of oral GLP-1 danuglipron for obesity 📅DATE: July 2024 📈📉IMPLIED VOLATILITY: +/- 10% https://lnkd.in/dTU6bjtf
-
-
Epoch 26: Innovative Trial Designs for Auto-Immune & Inflammatory Diseases 👉Early Signals of Efficacy 👉Umbrella Studies 👉Basket Studies https://lnkd.in/dEkBy2bY
-
-
Epoch 26: Do Failed Clinical Trials Matter? 👉 When bad data goes….right? 👉 Where missing an endpoint can be overcome 👉 Private market deal comps https://lnkd.in/dEkBy2bY
-
